What the study says

Plain-English summary

The review mapped behavioral, clinical, and policy interventions aimed at bisphenol and phthalate exposure.

Forty-seven of 58 interventions reported a decrease in at least one exposure biomarker.

The authors found the largest reductions in policy interventions, a reminder that safer defaults can matter more than perfect shopping.

Why it matters

Context

Product choices can help, but people cannot shop their way out of every exposure source. Be Gone Goods pairs practical purchasing help with support for stronger ingredient disclosure and safer systems.

What it cannot prove

Limitations

The included interventions differed widely in design, duration, population, and chemicals measured, so their results should not be treated as directly comparable.

Proportionate next steps

Practical actions

  • Start with high-frequency, easy-to-change sources.
  • Support policies that reduce exposure across whole populations.
  • Use biomarker studies as direction, not proof that a specific product changes health outcomes.

Read it yourself

Original source

Effects of behavioral, clinical, and policy interventions in reducing human exposure to bisphenols and phthalates: a scoping review

DOI: 10.1289/EHP11760

Open the paper or record →